Lixiao Xing

5PUBLICATIONS
21CO-AUTHORS
NanomaterialsInnate immunityGene and molecular therapyGlycoconjugatesMedical virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 17, 2026
Precision-engineered STING agonist nanoparticles enable coordinated mucosal-systemic immunity for durable pan-β-coronavirus protection.

|Mar 27, 2025
STING agonist-based ER-targeting molecules boost antigen cross-presentation.

Xiafeng Wang, Zhangping Huang, Lixiao Xing

|Sep 28, 2023
IgG Fc-Binding Peptide-Conjugated Pan-CoV Fusion Inhibitor Exhibits Extended In Vivo Half-Life and Synergistic Antiviral Effect When Combined with Neutralizing Antibodies.

Xiaojie Su, Ziqi Huang, Wei Xu

|Jun 10, 2023
A dePEGylated Lipopeptide-Based Pan-Coronavirus Fusion Inhibitor Exhibits Potent and Broad-Spectrum Anti-HIV-1 Activity without Eliciting Anti-PEG Antibodies.

Ling Xu, Chao Wang, Wei Xu

|Mar 26, 2022
A Five-Helix-Based SARS-CoV-2 Fusion Inhibitor Targeting Heptad Repeat 2 Domain against SARS-CoV-2 and Its Variants of Concern.

Lixiao Xing, Xinfeng Xu, Wei Xu

Pageof 1

Frequent Collaborators

5 joint publications

Lu Lu

5 joint publications

Shibo Jiang

2 joint publications

Qian Wang

2 joint publications

Ji Wang